- $724.10m
- $866.53m
- $1.53bn
- 80
- 67
- 50
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,297 | 1,158 | 1,685 | 1,946 | 1,534 |
Cost of Revenue | |||||
Gross Profit | 146 | 134 | 274 | 314 | 165 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,237 | 1,095 | 1,493 | 1,719 | 1,464 |
Operating Profit | 60.1 | 62.9 | 191 | 227 | 69.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 53.3 | 55 | 185 | 226 | 69.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.3 | 46.1 | 140 | 172 | 54.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 41.3 | 46.1 | 140 | 172 | 54.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 41.3 | 46.1 | 140 | 172 | 54.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.73 | 1.64 | 4.81 | 5.93 | 1.82 |
Dividends per Share |